« Previous
Next »
American Journal of Cardiology
Volume 96, Issue 5
, Pages
617-621
, 1 September 2005
Relation of C-Reactive Protein and One-Year Survival After Acute Myocardial Infarction With Versus Without Statin Therapy
-
Kaplan-Meier survival curves show that 1-year mortality rate was lower in patients who received statin therapy than in those who did not (1.4% vs 3.4%, log-rank test, p <0.001).
Kaplan-Meier survival curves show that 1-year mortality rate was lower in patients who received statin therapy than in those who did not (1.4% vs 3.4%, log-rank test, p <0.001).
-
Kaplan-Meier survival curves for 1-year mortality rate according to prescription of statin by subgroup: (A) Serum CRP level <2.9 mg/L and (B) CRP level ≥2.9 mg/L.
Kaplan-Meier survival curves for 1-year mortality rate according to prescription of statin by subgroup: (A) Serum CRP level <2.9 mg/L and (B) CRP level ≥2.9 mg/L.
-
HRs for 1-year mortality after AMI according to high versus low CRP level and prescription versus nonprescription of a statin. Adjustments were made for age, gender, body mass index, diabetes mellitus
HRs for 1-year mortality after AMI according to high versus low CRP level and prescription versus nonprescription of a statin. Adjustments were made for age, gender, body mass index, diabetes mellitus, hypertension, cholesterol level, current smoking, previous myocardial infarction, previous cerebrovascular disease, revascularization, Killip’s class ≥II, anterior wall myocardial infarction, and use of angiotensin-converting enzyme inhibitors, β blockers, and antiplatelet agents.
This work was supported by a Grant-in-Aid for Scientific Research (C)(2) (no. 15590743) from the Japan Society for the Promotion of Science, Tokyo, Japan, and by research funds from the Japan Arteriosclerosis Prevention Fund, Tokyo, Japan.
PII: S0002-9149(05)00926-4
doi: 10.1016/j.amjcard.2005.04.030
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 96, Issue 5
, Pages
617-621
, 1 September 2005
